126 related articles for article (PubMed ID: 11061361)
1. Endothelial dysfunction in chronic heart failure: some new basic mechanisms.
Bachetti T
Ital Heart J; 2000 Oct; 1(10):656-61. PubMed ID: 11061361
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
Tousoulis D; Charakida M; Stefanadis C
Int J Cardiol; 2005 Apr; 100(3):347-53. PubMed ID: 15837076
[TBL] [Abstract][Full Text] [Related]
3. Chronic decrease in flow contributes to heart failure-induced endothelial dysfunction in rats.
Devaux C; Iglarz M; Richard V; Mulder P; Henrion D; Renet S; Henry JP; Thuillez C
Clin Exp Pharmacol Physiol; 2004; 31(5-6):302-5. PubMed ID: 15191402
[TBL] [Abstract][Full Text] [Related]
4. [Endothelial dysfunction in cardial failure: potential mechanisms].
Varin R; Mulder P; Richard V; Thuillez C
Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():29-34. PubMed ID: 9515111
[TBL] [Abstract][Full Text] [Related]
5. [The importance of the endothelium in heart failure].
Leite-Moreira AF; Cerqueira-Gomes M
Rev Port Cardiol; 1997 Apr; 16(4):399-406, 353. PubMed ID: 9254129
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death.
Fischer D; Rossa S; Landmesser U; Spiekermann S; Engberding N; Hornig B; Drexler H
Eur Heart J; 2005 Jan; 26(1):65-9. PubMed ID: 15615801
[TBL] [Abstract][Full Text] [Related]
7. [Oxidative stress and endothelial dysfunction in heart failure].
Devaux C; Varin R; Mulder P; Richard V; Thuillez C
Therapie; 2001; 56(5):575-81. PubMed ID: 11806296
[TBL] [Abstract][Full Text] [Related]
8. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
[TBL] [Abstract][Full Text] [Related]
9. [Role of nitric oxide in heart failure].
Le Corvoisier P; Lopes ME; Su J; Hittinger L
J Soc Biol; 2000; 194(3-4):143-9. PubMed ID: 11324316
[TBL] [Abstract][Full Text] [Related]
10. [Sympathetic nervous system and endothelial function in heart failure].
Binggeli C; Wenzel RR; Noll G
Praxis (Bern 1994); 1996 Feb; 85(8):234-44. PubMed ID: 8701190
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor-mediated vasodilatation: effects of organ culture.
Nilsson D; Wackenfors A; Gustafsson L; Ugander M; Paulsson P; Ingemansson R; Edvinsson L; Malmsjö M
Eur J Pharmacol; 2008 Jan; 579(1-3):233-40. PubMed ID: 17964568
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
13. Alteration of endothelium-mediated vasodilator response in the rat hindlimb vasculature consecutive to chronic hypoxic stress: NO and EDHF involvement.
Reboul C; Gibault A; Tanguy S; Dauzat M; Obert P
Vascul Pharmacol; 2009; 51(2-3):154-61. PubMed ID: 19520187
[TBL] [Abstract][Full Text] [Related]
14. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
15. Exercise training and endothelial dysfunction in coronary artery disease and chronic heart failure. From molecular biology to clinical benefits.
Gielen S; Erbs S; Schuler G; Hambrecht R
Minerva Cardioangiol; 2002 Apr; 50(2):95-106. PubMed ID: 12032463
[TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular risk factors, erection disorders and endothelium dysfunction].
Behr-Roussel D
J Soc Biol; 2004; 198(3):237-41. PubMed ID: 15662940
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction.
Endemann DH; Schiffrin EL
J Am Soc Nephrol; 2004 Aug; 15(8):1983-92. PubMed ID: 15284284
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
20. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
Miller AL
Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
